Recently approved drugs for the treatment of multiple myeloma
How far are we from a cure for CLL?
Obinutuzumab (GA101) plus bendamustine as front-line therapy in CLL
Ibrutinib vs temsirolimus in relapsed/refractory mantle cell lymphoma
Measuring treatment response rates in multiple myeloma